nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—SLCO1A2—Chlorambucil—testicular cancer	0.089	0.118	CbGbCtD
Saquinavir—ABCC1—Dactinomycin—testicular cancer	0.0479	0.0633	CbGbCtD
Saquinavir—ABCC1—Epirubicin—testicular cancer	0.0347	0.0458	CbGbCtD
Saquinavir—ABCG2—Dactinomycin—testicular cancer	0.032	0.0423	CbGbCtD
Saquinavir—ABCC1—Vinblastine—testicular cancer	0.03	0.0396	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0279	0.0369	CbGbCtD
Saquinavir—CYP3A7—Ifosfamide—testicular cancer	0.0279	0.0369	CbGbCtD
Saquinavir—ABCC1—Etoposide—testicular cancer	0.027	0.0357	CbGbCtD
Saquinavir—ABCC2—Carboplatin—testicular cancer	0.0238	0.0315	CbGbCtD
Saquinavir—ABCC2—Vinblastine—testicular cancer	0.0222	0.0293	CbGbCtD
Saquinavir—ABCG2—Carboplatin—testicular cancer	0.0215	0.0285	CbGbCtD
Saquinavir—CYP3A5—Ifosfamide—testicular cancer	0.021	0.0277	CbGbCtD
Saquinavir—ABCC2—Cisplatin—testicular cancer	0.0204	0.0269	CbGbCtD
Saquinavir—CYP2C8—Ifosfamide—testicular cancer	0.0202	0.0266	CbGbCtD
Saquinavir—ABCC2—Etoposide—testicular cancer	0.02	0.0264	CbGbCtD
Saquinavir—CYP11A1—corpus luteum—testicular cancer	0.0187	0.375	CbGeAlD
Saquinavir—ABCC1—Doxorubicin—testicular cancer	0.0184	0.0243	CbGbCtD
Saquinavir—ABCG2—Cisplatin—testicular cancer	0.0184	0.0243	CbGbCtD
Saquinavir—ABCG2—Etoposide—testicular cancer	0.0181	0.0239	CbGbCtD
Saquinavir—ABCC1—Methotrexate—testicular cancer	0.0178	0.0236	CbGbCtD
Saquinavir—CYP2C19—Ifosfamide—testicular cancer	0.0169	0.0223	CbGbCtD
Saquinavir—SLCO1A2—Methotrexate—testicular cancer	0.0159	0.0211	CbGbCtD
Saquinavir—CYP11A1—seminiferous tubule of testis—testicular cancer	0.0159	0.318	CbGeAlD
Saquinavir—SLCO1B1—Methotrexate—testicular cancer	0.015	0.0199	CbGbCtD
Saquinavir—CYP2C9—Ifosfamide—testicular cancer	0.0141	0.0186	CbGbCtD
Saquinavir—ABCC2—Doxorubicin—testicular cancer	0.0136	0.018	CbGbCtD
Saquinavir—ABCC2—Methotrexate—testicular cancer	0.0132	0.0175	CbGbCtD
Saquinavir—ABCG2—Doxorubicin—testicular cancer	0.0123	0.0163	CbGbCtD
Saquinavir—ABCG2—Methotrexate—testicular cancer	0.0119	0.0158	CbGbCtD
Saquinavir—ABCB1—Dactinomycin—testicular cancer	0.0116	0.0153	CbGbCtD
Saquinavir—CYP3A5—Etoposide—testicular cancer	0.01	0.0132	CbGbCtD
Saquinavir—CYP2C8—Etoposide—testicular cancer	0.00963	0.0127	CbGbCtD
Saquinavir—ALB—Methotrexate—testicular cancer	0.00823	0.0109	CbGbCtD
Saquinavir—CYP3A4—Ifosfamide—testicular cancer	0.00817	0.0108	CbGbCtD
Saquinavir—ABCB1—Vinblastine—testicular cancer	0.00724	0.00956	CbGbCtD
Saquinavir—CYP2C9—Cisplatin—testicular cancer	0.00684	0.00903	CbGbCtD
Saquinavir—CYP2D6—Vinblastine—testicular cancer	0.00682	0.00901	CbGbCtD
Saquinavir—ABCB1—Cisplatin—testicular cancer	0.00663	0.00877	CbGbCtD
Saquinavir—ABCB1—Etoposide—testicular cancer	0.00652	0.00861	CbGbCtD
Saquinavir—ABCB1—Doxorubicin—testicular cancer	0.00445	0.00587	CbGbCtD
Saquinavir—CYP3A4—Vinblastine—testicular cancer	0.00434	0.00573	CbGbCtD
Saquinavir—ABCB1—Methotrexate—testicular cancer	0.00431	0.00569	CbGbCtD
Saquinavir—CYP2D6—Doxorubicin—testicular cancer	0.00419	0.00554	CbGbCtD
Saquinavir—CYP3A4—Etoposide—testicular cancer	0.00391	0.00516	CbGbCtD
Saquinavir—CYP3A4—Doxorubicin—testicular cancer	0.00266	0.00352	CbGbCtD
Saquinavir—CYP11A1—gonad—testicular cancer	0.00134	0.0269	CbGeAlD
Saquinavir—CYP11A1—female gonad—testicular cancer	0.00109	0.0219	CbGeAlD
Saquinavir—ABCC1—seminal vesicle—testicular cancer	0.00102	0.0203	CbGeAlD
Saquinavir—CYP11A1—testis—testicular cancer	0.000969	0.0194	CbGeAlD
Saquinavir—ABCG2—seminal vesicle—testicular cancer	0.000841	0.0168	CbGeAlD
Saquinavir—CYP11A1—lymph node—testicular cancer	0.000702	0.0141	CbGeAlD
Saquinavir—SLCO1A2—testis—testicular cancer	0.000645	0.0129	CbGeAlD
Saquinavir—ALB—testis—testicular cancer	0.000641	0.0128	CbGeAlD
Saquinavir—ABCC2—testis—testicular cancer	0.000601	0.012	CbGeAlD
Saquinavir—ABCC1—female gonad—testicular cancer	0.000597	0.0119	CbGeAlD
Saquinavir—ORM1—lymph node—testicular cancer	0.00053	0.0106	CbGeAlD
Saquinavir—ABCC1—testis—testicular cancer	0.000529	0.0106	CbGeAlD
Saquinavir—ABCG2—female gonad—testicular cancer	0.000494	0.00989	CbGeAlD
Saquinavir—ALB—lymph node—testicular cancer	0.000465	0.0093	CbGeAlD
Saquinavir—CYP3A5—female gonad—testicular cancer	0.000459	0.00918	CbGeAlD
Saquinavir—CYP2C8—testis—testicular cancer	0.000451	0.00902	CbGeAlD
Saquinavir—ABCB1—embryo—testicular cancer	0.000442	0.00884	CbGeAlD
Saquinavir—ABCG2—testis—testicular cancer	0.000438	0.00877	CbGeAlD
Saquinavir—ABCC2—lymph node—testicular cancer	0.000436	0.00872	CbGeAlD
Saquinavir—ABCB1—seminal vesicle—testicular cancer	0.000415	0.0083	CbGeAlD
Saquinavir—ABCC1—lymph node—testicular cancer	0.000384	0.00768	CbGeAlD
Saquinavir—CYP2D6—female gonad—testicular cancer	0.000339	0.00678	CbGeAlD
Saquinavir—ABCG2—lymph node—testicular cancer	0.000318	0.00636	CbGeAlD
Saquinavir—CYP2D6—testis—testicular cancer	0.0003	0.00601	CbGeAlD
Saquinavir—ABCB1—gonad—testicular cancer	0.0003	0.006	CbGeAlD
Saquinavir—ABCB1—female gonad—testicular cancer	0.000244	0.00488	CbGeAlD
Saquinavir—ABCB1—testis—testicular cancer	0.000216	0.00433	CbGeAlD
Saquinavir—ABCB1—lymph node—testicular cancer	0.000157	0.00314	CbGeAlD
Saquinavir—Renal failure—Doxorubicin—testicular cancer	8.04e-05	0.000416	CcSEcCtD
Saquinavir—Rash—Ifosfamide—testicular cancer	8.03e-05	0.000416	CcSEcCtD
Saquinavir—Dermatitis—Ifosfamide—testicular cancer	8.02e-05	0.000415	CcSEcCtD
Saquinavir—Erythema multiforme—Methotrexate—testicular cancer	8.02e-05	0.000415	CcSEcCtD
Saquinavir—Neuropathy peripheral—Doxorubicin—testicular cancer	8.02e-05	0.000415	CcSEcCtD
Saquinavir—Urticaria—Etoposide—testicular cancer	7.99e-05	0.000414	CcSEcCtD
Saquinavir—Haemoglobin—Epirubicin—testicular cancer	7.98e-05	0.000413	CcSEcCtD
Saquinavir—Jaundice—Doxorubicin—testicular cancer	7.97e-05	0.000413	CcSEcCtD
Saquinavir—Stomatitis—Doxorubicin—testicular cancer	7.97e-05	0.000413	CcSEcCtD
Saquinavir—Rhinitis—Epirubicin—testicular cancer	7.96e-05	0.000412	CcSEcCtD
Saquinavir—Abdominal pain—Etoposide—testicular cancer	7.95e-05	0.000412	CcSEcCtD
Saquinavir—Body temperature increased—Etoposide—testicular cancer	7.95e-05	0.000412	CcSEcCtD
Saquinavir—Urinary tract infection—Doxorubicin—testicular cancer	7.95e-05	0.000412	CcSEcCtD
Saquinavir—Conjunctivitis—Doxorubicin—testicular cancer	7.95e-05	0.000412	CcSEcCtD
Saquinavir—Hepatitis—Epirubicin—testicular cancer	7.94e-05	0.000411	CcSEcCtD
Saquinavir—Haemorrhage—Epirubicin—testicular cancer	7.94e-05	0.000411	CcSEcCtD
Saquinavir—Eye disorder—Methotrexate—testicular cancer	7.93e-05	0.00041	CcSEcCtD
Saquinavir—Tinnitus—Methotrexate—testicular cancer	7.91e-05	0.000409	CcSEcCtD
Saquinavir—Hypoaesthesia—Epirubicin—testicular cancer	7.9e-05	0.000409	CcSEcCtD
Saquinavir—Asthenia—Cisplatin—testicular cancer	7.88e-05	0.000408	CcSEcCtD
Saquinavir—Pharyngitis—Epirubicin—testicular cancer	7.88e-05	0.000408	CcSEcCtD
Saquinavir—Cardiac disorder—Methotrexate—testicular cancer	7.87e-05	0.000407	CcSEcCtD
Saquinavir—Urinary tract disorder—Epirubicin—testicular cancer	7.84e-05	0.000406	CcSEcCtD
Saquinavir—Connective tissue disorder—Epirubicin—testicular cancer	7.8e-05	0.000404	CcSEcCtD
Saquinavir—Urethral disorder—Epirubicin—testicular cancer	7.78e-05	0.000403	CcSEcCtD
Saquinavir—Hepatobiliary disease—Doxorubicin—testicular cancer	7.74e-05	0.0004	CcSEcCtD
Saquinavir—Epistaxis—Doxorubicin—testicular cancer	7.72e-05	0.000399	CcSEcCtD
Saquinavir—Angiopathy—Methotrexate—testicular cancer	7.7e-05	0.000398	CcSEcCtD
Saquinavir—Sinusitis—Doxorubicin—testicular cancer	7.68e-05	0.000397	CcSEcCtD
Saquinavir—Immune system disorder—Methotrexate—testicular cancer	7.66e-05	0.000397	CcSEcCtD
Saquinavir—Visual impairment—Epirubicin—testicular cancer	7.65e-05	0.000396	CcSEcCtD
Saquinavir—Mediastinal disorder—Methotrexate—testicular cancer	7.64e-05	0.000396	CcSEcCtD
Saquinavir—Chills—Methotrexate—testicular cancer	7.61e-05	0.000394	CcSEcCtD
Saquinavir—Nausea—Ifosfamide—testicular cancer	7.57e-05	0.000392	CcSEcCtD
Saquinavir—Diarrhoea—Cisplatin—testicular cancer	7.51e-05	0.000389	CcSEcCtD
Saquinavir—Erythema multiforme—Epirubicin—testicular cancer	7.51e-05	0.000388	CcSEcCtD
Saquinavir—Alopecia—Methotrexate—testicular cancer	7.5e-05	0.000388	CcSEcCtD
Saquinavir—Mental disorder—Methotrexate—testicular cancer	7.43e-05	0.000385	CcSEcCtD
Saquinavir—Eye disorder—Epirubicin—testicular cancer	7.42e-05	0.000384	CcSEcCtD
Saquinavir—Hypersensitivity—Etoposide—testicular cancer	7.41e-05	0.000384	CcSEcCtD
Saquinavir—Tinnitus—Epirubicin—testicular cancer	7.4e-05	0.000383	CcSEcCtD
Saquinavir—Erythema—Methotrexate—testicular cancer	7.38e-05	0.000382	CcSEcCtD
Saquinavir—Malnutrition—Methotrexate—testicular cancer	7.38e-05	0.000382	CcSEcCtD
Saquinavir—Haemoglobin—Doxorubicin—testicular cancer	7.38e-05	0.000382	CcSEcCtD
Saquinavir—Cardiac disorder—Epirubicin—testicular cancer	7.37e-05	0.000381	CcSEcCtD
Saquinavir—Rhinitis—Doxorubicin—testicular cancer	7.36e-05	0.000381	CcSEcCtD
Saquinavir—Haemorrhage—Doxorubicin—testicular cancer	7.34e-05	0.00038	CcSEcCtD
Saquinavir—Hepatitis—Doxorubicin—testicular cancer	7.34e-05	0.00038	CcSEcCtD
Saquinavir—Hypoaesthesia—Doxorubicin—testicular cancer	7.31e-05	0.000378	CcSEcCtD
Saquinavir—Pharyngitis—Doxorubicin—testicular cancer	7.29e-05	0.000377	CcSEcCtD
Saquinavir—Urinary tract disorder—Doxorubicin—testicular cancer	7.25e-05	0.000375	CcSEcCtD
Saquinavir—Dysgeusia—Methotrexate—testicular cancer	7.23e-05	0.000374	CcSEcCtD
Saquinavir—Asthenia—Etoposide—testicular cancer	7.22e-05	0.000374	CcSEcCtD
Saquinavir—Connective tissue disorder—Doxorubicin—testicular cancer	7.22e-05	0.000374	CcSEcCtD
Saquinavir—Angiopathy—Epirubicin—testicular cancer	7.2e-05	0.000373	CcSEcCtD
Saquinavir—Urethral disorder—Doxorubicin—testicular cancer	7.2e-05	0.000373	CcSEcCtD
Saquinavir—Immune system disorder—Epirubicin—testicular cancer	7.17e-05	0.000371	CcSEcCtD
Saquinavir—Mediastinal disorder—Epirubicin—testicular cancer	7.15e-05	0.00037	CcSEcCtD
Saquinavir—Back pain—Methotrexate—testicular cancer	7.14e-05	0.00037	CcSEcCtD
Saquinavir—Chills—Epirubicin—testicular cancer	7.12e-05	0.000369	CcSEcCtD
Saquinavir—Pruritus—Etoposide—testicular cancer	7.12e-05	0.000368	CcSEcCtD
Saquinavir—Visual impairment—Doxorubicin—testicular cancer	7.08e-05	0.000366	CcSEcCtD
Saquinavir—Alopecia—Epirubicin—testicular cancer	7.01e-05	0.000363	CcSEcCtD
Saquinavir—Vomiting—Cisplatin—testicular cancer	6.98e-05	0.000361	CcSEcCtD
Saquinavir—Mental disorder—Epirubicin—testicular cancer	6.95e-05	0.00036	CcSEcCtD
Saquinavir—Erythema multiforme—Doxorubicin—testicular cancer	6.94e-05	0.000359	CcSEcCtD
Saquinavir—Rash—Cisplatin—testicular cancer	6.92e-05	0.000358	CcSEcCtD
Saquinavir—Dermatitis—Cisplatin—testicular cancer	6.92e-05	0.000358	CcSEcCtD
Saquinavir—Erythema—Epirubicin—testicular cancer	6.91e-05	0.000358	CcSEcCtD
Saquinavir—Malnutrition—Epirubicin—testicular cancer	6.91e-05	0.000358	CcSEcCtD
Saquinavir—Diarrhoea—Etoposide—testicular cancer	6.88e-05	0.000356	CcSEcCtD
Saquinavir—Eye disorder—Doxorubicin—testicular cancer	6.86e-05	0.000355	CcSEcCtD
Saquinavir—Ill-defined disorder—Methotrexate—testicular cancer	6.85e-05	0.000355	CcSEcCtD
Saquinavir—Tinnitus—Doxorubicin—testicular cancer	6.85e-05	0.000354	CcSEcCtD
Saquinavir—Anaemia—Methotrexate—testicular cancer	6.82e-05	0.000353	CcSEcCtD
Saquinavir—Cardiac disorder—Doxorubicin—testicular cancer	6.82e-05	0.000353	CcSEcCtD
Saquinavir—Flatulence—Epirubicin—testicular cancer	6.81e-05	0.000352	CcSEcCtD
Saquinavir—Dysgeusia—Epirubicin—testicular cancer	6.77e-05	0.00035	CcSEcCtD
Saquinavir—Back pain—Epirubicin—testicular cancer	6.68e-05	0.000346	CcSEcCtD
Saquinavir—Angiopathy—Doxorubicin—testicular cancer	6.66e-05	0.000345	CcSEcCtD
Saquinavir—Malaise—Methotrexate—testicular cancer	6.66e-05	0.000345	CcSEcCtD
Saquinavir—Dizziness—Etoposide—testicular cancer	6.65e-05	0.000344	CcSEcCtD
Saquinavir—Muscle spasms—Epirubicin—testicular cancer	6.64e-05	0.000344	CcSEcCtD
Saquinavir—Immune system disorder—Doxorubicin—testicular cancer	6.63e-05	0.000343	CcSEcCtD
Saquinavir—Vertigo—Methotrexate—testicular cancer	6.63e-05	0.000343	CcSEcCtD
Saquinavir—Mediastinal disorder—Doxorubicin—testicular cancer	6.62e-05	0.000343	CcSEcCtD
Saquinavir—Leukopenia—Methotrexate—testicular cancer	6.61e-05	0.000342	CcSEcCtD
Saquinavir—Chills—Doxorubicin—testicular cancer	6.59e-05	0.000341	CcSEcCtD
Saquinavir—Nausea—Cisplatin—testicular cancer	6.52e-05	0.000338	CcSEcCtD
Saquinavir—Alopecia—Doxorubicin—testicular cancer	6.49e-05	0.000336	CcSEcCtD
Saquinavir—Cough—Methotrexate—testicular cancer	6.44e-05	0.000333	CcSEcCtD
Saquinavir—Mental disorder—Doxorubicin—testicular cancer	6.43e-05	0.000333	CcSEcCtD
Saquinavir—Ill-defined disorder—Epirubicin—testicular cancer	6.41e-05	0.000332	CcSEcCtD
Saquinavir—Convulsion—Methotrexate—testicular cancer	6.4e-05	0.000331	CcSEcCtD
Saquinavir—Vomiting—Etoposide—testicular cancer	6.4e-05	0.000331	CcSEcCtD
Saquinavir—Erythema—Doxorubicin—testicular cancer	6.39e-05	0.000331	CcSEcCtD
Saquinavir—Malnutrition—Doxorubicin—testicular cancer	6.39e-05	0.000331	CcSEcCtD
Saquinavir—Anaemia—Epirubicin—testicular cancer	6.39e-05	0.000331	CcSEcCtD
Saquinavir—Agitation—Epirubicin—testicular cancer	6.35e-05	0.000329	CcSEcCtD
Saquinavir—Rash—Etoposide—testicular cancer	6.34e-05	0.000328	CcSEcCtD
Saquinavir—Dermatitis—Etoposide—testicular cancer	6.34e-05	0.000328	CcSEcCtD
Saquinavir—Headache—Etoposide—testicular cancer	6.3e-05	0.000326	CcSEcCtD
Saquinavir—Flatulence—Doxorubicin—testicular cancer	6.3e-05	0.000326	CcSEcCtD
Saquinavir—Arthralgia—Methotrexate—testicular cancer	6.29e-05	0.000325	CcSEcCtD
Saquinavir—Myalgia—Methotrexate—testicular cancer	6.29e-05	0.000325	CcSEcCtD
Saquinavir—Chest pain—Methotrexate—testicular cancer	6.29e-05	0.000325	CcSEcCtD
Saquinavir—Dysgeusia—Doxorubicin—testicular cancer	6.26e-05	0.000324	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	6.24e-05	0.000323	CcSEcCtD
Saquinavir—Malaise—Epirubicin—testicular cancer	6.23e-05	0.000322	CcSEcCtD
Saquinavir—Discomfort—Methotrexate—testicular cancer	6.21e-05	0.000321	CcSEcCtD
Saquinavir—Vertigo—Epirubicin—testicular cancer	6.21e-05	0.000321	CcSEcCtD
Saquinavir—Syncope—Epirubicin—testicular cancer	6.2e-05	0.000321	CcSEcCtD
Saquinavir—Leukopenia—Epirubicin—testicular cancer	6.19e-05	0.00032	CcSEcCtD
Saquinavir—Back pain—Doxorubicin—testicular cancer	6.18e-05	0.00032	CcSEcCtD
Saquinavir—Muscle spasms—Doxorubicin—testicular cancer	6.15e-05	0.000318	CcSEcCtD
Saquinavir—Confusional state—Methotrexate—testicular cancer	6.08e-05	0.000314	CcSEcCtD
Saquinavir—Loss of consciousness—Epirubicin—testicular cancer	6.07e-05	0.000314	CcSEcCtD
Saquinavir—Cough—Epirubicin—testicular cancer	6.03e-05	0.000312	CcSEcCtD
Saquinavir—Convulsion—Epirubicin—testicular cancer	5.99e-05	0.00031	CcSEcCtD
Saquinavir—Infection—Methotrexate—testicular cancer	5.99e-05	0.00031	CcSEcCtD
Saquinavir—Nausea—Etoposide—testicular cancer	5.98e-05	0.000309	CcSEcCtD
Saquinavir—Hypertension—Epirubicin—testicular cancer	5.97e-05	0.000309	CcSEcCtD
Saquinavir—Ill-defined disorder—Doxorubicin—testicular cancer	5.93e-05	0.000307	CcSEcCtD
Saquinavir—Nervous system disorder—Methotrexate—testicular cancer	5.91e-05	0.000306	CcSEcCtD
Saquinavir—Anaemia—Doxorubicin—testicular cancer	5.91e-05	0.000306	CcSEcCtD
Saquinavir—Thrombocytopenia—Methotrexate—testicular cancer	5.9e-05	0.000305	CcSEcCtD
Saquinavir—Myalgia—Epirubicin—testicular cancer	5.88e-05	0.000304	CcSEcCtD
Saquinavir—Chest pain—Epirubicin—testicular cancer	5.88e-05	0.000304	CcSEcCtD
Saquinavir—Arthralgia—Epirubicin—testicular cancer	5.88e-05	0.000304	CcSEcCtD
Saquinavir—Agitation—Doxorubicin—testicular cancer	5.88e-05	0.000304	CcSEcCtD
Saquinavir—Anxiety—Epirubicin—testicular cancer	5.86e-05	0.000303	CcSEcCtD
Saquinavir—Skin disorder—Methotrexate—testicular cancer	5.85e-05	0.000303	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	5.84e-05	0.000302	CcSEcCtD
Saquinavir—Hyperhidrosis—Methotrexate—testicular cancer	5.83e-05	0.000301	CcSEcCtD
Saquinavir—Discomfort—Epirubicin—testicular cancer	5.81e-05	0.000301	CcSEcCtD
Saquinavir—Malaise—Doxorubicin—testicular cancer	5.77e-05	0.000298	CcSEcCtD
Saquinavir—Dry mouth—Epirubicin—testicular cancer	5.75e-05	0.000298	CcSEcCtD
Saquinavir—Vertigo—Doxorubicin—testicular cancer	5.74e-05	0.000297	CcSEcCtD
Saquinavir—Anorexia—Methotrexate—testicular cancer	5.74e-05	0.000297	CcSEcCtD
Saquinavir—Syncope—Doxorubicin—testicular cancer	5.73e-05	0.000297	CcSEcCtD
Saquinavir—Leukopenia—Doxorubicin—testicular cancer	5.72e-05	0.000296	CcSEcCtD
Saquinavir—Confusional state—Epirubicin—testicular cancer	5.69e-05	0.000294	CcSEcCtD
Saquinavir—Oedema—Epirubicin—testicular cancer	5.64e-05	0.000292	CcSEcCtD
Saquinavir—Hypotension—Methotrexate—testicular cancer	5.63e-05	0.000291	CcSEcCtD
Saquinavir—Loss of consciousness—Doxorubicin—testicular cancer	5.62e-05	0.000291	CcSEcCtD
Saquinavir—Infection—Epirubicin—testicular cancer	5.6e-05	0.00029	CcSEcCtD
Saquinavir—Cough—Doxorubicin—testicular cancer	5.58e-05	0.000289	CcSEcCtD
Saquinavir—Shock—Epirubicin—testicular cancer	5.55e-05	0.000287	CcSEcCtD
Saquinavir—Convulsion—Doxorubicin—testicular cancer	5.54e-05	0.000287	CcSEcCtD
Saquinavir—Nervous system disorder—Epirubicin—testicular cancer	5.53e-05	0.000286	CcSEcCtD
Saquinavir—Thrombocytopenia—Epirubicin—testicular cancer	5.52e-05	0.000286	CcSEcCtD
Saquinavir—Hypertension—Doxorubicin—testicular cancer	5.52e-05	0.000286	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Methotrexate—testicular cancer	5.49e-05	0.000284	CcSEcCtD
Saquinavir—Skin disorder—Epirubicin—testicular cancer	5.48e-05	0.000283	CcSEcCtD
Saquinavir—Hyperhidrosis—Epirubicin—testicular cancer	5.45e-05	0.000282	CcSEcCtD
Saquinavir—Insomnia—Methotrexate—testicular cancer	5.45e-05	0.000282	CcSEcCtD
Saquinavir—Myalgia—Doxorubicin—testicular cancer	5.44e-05	0.000282	CcSEcCtD
Saquinavir—Arthralgia—Doxorubicin—testicular cancer	5.44e-05	0.000282	CcSEcCtD
Saquinavir—Chest pain—Doxorubicin—testicular cancer	5.44e-05	0.000282	CcSEcCtD
Saquinavir—Anxiety—Doxorubicin—testicular cancer	5.42e-05	0.000281	CcSEcCtD
Saquinavir—Paraesthesia—Methotrexate—testicular cancer	5.41e-05	0.00028	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	5.41e-05	0.00028	CcSEcCtD
Saquinavir—Discomfort—Doxorubicin—testicular cancer	5.38e-05	0.000278	CcSEcCtD
Saquinavir—Anorexia—Epirubicin—testicular cancer	5.38e-05	0.000278	CcSEcCtD
Saquinavir—Dyspnoea—Methotrexate—testicular cancer	5.37e-05	0.000278	CcSEcCtD
Saquinavir—Somnolence—Methotrexate—testicular cancer	5.36e-05	0.000277	CcSEcCtD
Saquinavir—Dry mouth—Doxorubicin—testicular cancer	5.32e-05	0.000276	CcSEcCtD
Saquinavir—Dyspepsia—Methotrexate—testicular cancer	5.3e-05	0.000275	CcSEcCtD
Saquinavir—Hypotension—Epirubicin—testicular cancer	5.27e-05	0.000273	CcSEcCtD
Saquinavir—Confusional state—Doxorubicin—testicular cancer	5.26e-05	0.000272	CcSEcCtD
Saquinavir—Decreased appetite—Methotrexate—testicular cancer	5.24e-05	0.000271	CcSEcCtD
Saquinavir—Oedema—Doxorubicin—testicular cancer	5.22e-05	0.00027	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Methotrexate—testicular cancer	5.2e-05	0.000269	CcSEcCtD
Saquinavir—Fatigue—Methotrexate—testicular cancer	5.2e-05	0.000269	CcSEcCtD
Saquinavir—Infection—Doxorubicin—testicular cancer	5.18e-05	0.000268	CcSEcCtD
Saquinavir—Pain—Methotrexate—testicular cancer	5.15e-05	0.000267	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Epirubicin—testicular cancer	5.14e-05	0.000266	CcSEcCtD
Saquinavir—Shock—Doxorubicin—testicular cancer	5.13e-05	0.000266	CcSEcCtD
Saquinavir—Nervous system disorder—Doxorubicin—testicular cancer	5.12e-05	0.000265	CcSEcCtD
Saquinavir—Thrombocytopenia—Doxorubicin—testicular cancer	5.11e-05	0.000264	CcSEcCtD
Saquinavir—Insomnia—Epirubicin—testicular cancer	5.1e-05	0.000264	CcSEcCtD
Saquinavir—Skin disorder—Doxorubicin—testicular cancer	5.07e-05	0.000262	CcSEcCtD
Saquinavir—Paraesthesia—Epirubicin—testicular cancer	5.06e-05	0.000262	CcSEcCtD
Saquinavir—Hyperhidrosis—Doxorubicin—testicular cancer	5.04e-05	0.000261	CcSEcCtD
Saquinavir—Dyspnoea—Epirubicin—testicular cancer	5.03e-05	0.00026	CcSEcCtD
Saquinavir—Somnolence—Epirubicin—testicular cancer	5.01e-05	0.000259	CcSEcCtD
Saquinavir—Anorexia—Doxorubicin—testicular cancer	4.97e-05	0.000257	CcSEcCtD
Saquinavir—Feeling abnormal—Methotrexate—testicular cancer	4.97e-05	0.000257	CcSEcCtD
Saquinavir—Dyspepsia—Epirubicin—testicular cancer	4.96e-05	0.000257	CcSEcCtD
Saquinavir—Gastrointestinal pain—Methotrexate—testicular cancer	4.93e-05	0.000255	CcSEcCtD
Saquinavir—Decreased appetite—Epirubicin—testicular cancer	4.9e-05	0.000254	CcSEcCtD
Saquinavir—Hypotension—Doxorubicin—testicular cancer	4.88e-05	0.000252	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Epirubicin—testicular cancer	4.87e-05	0.000252	CcSEcCtD
Saquinavir—Fatigue—Epirubicin—testicular cancer	4.86e-05	0.000252	CcSEcCtD
Saquinavir—Constipation—Epirubicin—testicular cancer	4.82e-05	0.00025	CcSEcCtD
Saquinavir—Pain—Epirubicin—testicular cancer	4.82e-05	0.00025	CcSEcCtD
Saquinavir—Urticaria—Methotrexate—testicular cancer	4.79e-05	0.000248	CcSEcCtD
Saquinavir—Abdominal pain—Methotrexate—testicular cancer	4.76e-05	0.000247	CcSEcCtD
Saquinavir—Body temperature increased—Methotrexate—testicular cancer	4.76e-05	0.000247	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.75e-05	0.000246	CcSEcCtD
Saquinavir—Insomnia—Doxorubicin—testicular cancer	4.72e-05	0.000244	CcSEcCtD
Saquinavir—Paraesthesia—Doxorubicin—testicular cancer	4.69e-05	0.000242	CcSEcCtD
Saquinavir—Dyspnoea—Doxorubicin—testicular cancer	4.65e-05	0.000241	CcSEcCtD
Saquinavir—Feeling abnormal—Epirubicin—testicular cancer	4.65e-05	0.000241	CcSEcCtD
Saquinavir—Somnolence—Doxorubicin—testicular cancer	4.64e-05	0.00024	CcSEcCtD
Saquinavir—Gastrointestinal pain—Epirubicin—testicular cancer	4.61e-05	0.000239	CcSEcCtD
Saquinavir—Dyspepsia—Doxorubicin—testicular cancer	4.59e-05	0.000238	CcSEcCtD
Saquinavir—Decreased appetite—Doxorubicin—testicular cancer	4.54e-05	0.000235	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Doxorubicin—testicular cancer	4.5e-05	0.000233	CcSEcCtD
Saquinavir—Fatigue—Doxorubicin—testicular cancer	4.5e-05	0.000233	CcSEcCtD
Saquinavir—Urticaria—Epirubicin—testicular cancer	4.48e-05	0.000232	CcSEcCtD
Saquinavir—Pain—Doxorubicin—testicular cancer	4.46e-05	0.000231	CcSEcCtD
Saquinavir—Constipation—Doxorubicin—testicular cancer	4.46e-05	0.000231	CcSEcCtD
Saquinavir—Abdominal pain—Epirubicin—testicular cancer	4.46e-05	0.000231	CcSEcCtD
Saquinavir—Body temperature increased—Epirubicin—testicular cancer	4.46e-05	0.000231	CcSEcCtD
Saquinavir—Hypersensitivity—Methotrexate—testicular cancer	4.44e-05	0.00023	CcSEcCtD
Saquinavir—Asthenia—Methotrexate—testicular cancer	4.32e-05	0.000224	CcSEcCtD
Saquinavir—Feeling abnormal—Doxorubicin—testicular cancer	4.3e-05	0.000223	CcSEcCtD
Saquinavir—Gastrointestinal pain—Doxorubicin—testicular cancer	4.27e-05	0.000221	CcSEcCtD
Saquinavir—Pruritus—Methotrexate—testicular cancer	4.26e-05	0.000221	CcSEcCtD
Saquinavir—Hypersensitivity—Epirubicin—testicular cancer	4.15e-05	0.000215	CcSEcCtD
Saquinavir—Urticaria—Doxorubicin—testicular cancer	4.15e-05	0.000215	CcSEcCtD
Saquinavir—Abdominal pain—Doxorubicin—testicular cancer	4.13e-05	0.000213	CcSEcCtD
Saquinavir—Body temperature increased—Doxorubicin—testicular cancer	4.13e-05	0.000213	CcSEcCtD
Saquinavir—Diarrhoea—Methotrexate—testicular cancer	4.12e-05	0.000213	CcSEcCtD
Saquinavir—Asthenia—Epirubicin—testicular cancer	4.05e-05	0.000209	CcSEcCtD
Saquinavir—Pruritus—Epirubicin—testicular cancer	3.99e-05	0.000206	CcSEcCtD
Saquinavir—Dizziness—Methotrexate—testicular cancer	3.98e-05	0.000206	CcSEcCtD
Saquinavir—Diarrhoea—Epirubicin—testicular cancer	3.86e-05	0.0002	CcSEcCtD
Saquinavir—Hypersensitivity—Doxorubicin—testicular cancer	3.84e-05	0.000199	CcSEcCtD
Saquinavir—Vomiting—Methotrexate—testicular cancer	3.83e-05	0.000198	CcSEcCtD
Saquinavir—Rash—Methotrexate—testicular cancer	3.8e-05	0.000197	CcSEcCtD
Saquinavir—Dermatitis—Methotrexate—testicular cancer	3.8e-05	0.000196	CcSEcCtD
Saquinavir—Headache—Methotrexate—testicular cancer	3.78e-05	0.000195	CcSEcCtD
Saquinavir—Asthenia—Doxorubicin—testicular cancer	3.74e-05	0.000194	CcSEcCtD
Saquinavir—Dizziness—Epirubicin—testicular cancer	3.73e-05	0.000193	CcSEcCtD
Saquinavir—Pruritus—Doxorubicin—testicular cancer	3.69e-05	0.000191	CcSEcCtD
Saquinavir—Vomiting—Epirubicin—testicular cancer	3.59e-05	0.000186	CcSEcCtD
Saquinavir—Nausea—Methotrexate—testicular cancer	3.58e-05	0.000185	CcSEcCtD
Saquinavir—Diarrhoea—Doxorubicin—testicular cancer	3.57e-05	0.000185	CcSEcCtD
Saquinavir—Rash—Epirubicin—testicular cancer	3.56e-05	0.000184	CcSEcCtD
Saquinavir—Dermatitis—Epirubicin—testicular cancer	3.55e-05	0.000184	CcSEcCtD
Saquinavir—Headache—Epirubicin—testicular cancer	3.53e-05	0.000183	CcSEcCtD
Saquinavir—Dizziness—Doxorubicin—testicular cancer	3.45e-05	0.000179	CcSEcCtD
Saquinavir—Nausea—Epirubicin—testicular cancer	3.35e-05	0.000173	CcSEcCtD
Saquinavir—Vomiting—Doxorubicin—testicular cancer	3.32e-05	0.000172	CcSEcCtD
Saquinavir—Rash—Doxorubicin—testicular cancer	3.29e-05	0.00017	CcSEcCtD
Saquinavir—Dermatitis—Doxorubicin—testicular cancer	3.29e-05	0.00017	CcSEcCtD
Saquinavir—Headache—Doxorubicin—testicular cancer	3.27e-05	0.000169	CcSEcCtD
Saquinavir—Nausea—Doxorubicin—testicular cancer	3.1e-05	0.00016	CcSEcCtD
